Trident Texofab [TTFL] vs KPR Mill [KPRMILL] Detailed Stock Comparison

Trident Texofab

BSE
Loading...

KPR Mill

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Trident Texofab wins in 5 metrics, KPR Mill wins in 14 metrics, with 0 ties. KPR Mill appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricTrident TexofabKPR MillBetter
P/E Ratio (TTM)158.9444.45KPR Mill
Price-to-Book Ratio7.327.32Trident Texofab
Debt-to-Equity Ratio62.679.32KPR Mill
PEG Ratio36.569.80KPR Mill
EV/EBITDA83.3228.95KPR Mill
Profit Margin (TTM)2.28%12.60%KPR Mill
Operating Margin (TTM)5.90%14.55%KPR Mill
EBITDA Margin (TTM)5.90%14.55%KPR Mill
Return on Equity5.31%16.30%KPR Mill
Return on Assets (TTM)2.50%13.67%KPR Mill
Free Cash Flow (TTM)$-137.22M$12.33BKPR Mill
Dividend YieldN/A0.40%N/A
1-Year Return606.97%13.31%Trident Texofab
Price-to-Sales Ratio (TTM)4.085.59Trident Texofab
Enterprise Value$5.04B$364.88BKPR Mill
EV/Revenue Ratio4.055.58Trident Texofab
Gross Profit Margin (TTM)15.72%32.90%KPR Mill
Revenue per Share (TTM)$108$191KPR Mill
Earnings per Share (Diluted)$2.13$24.09KPR Mill
Beta (Stock Volatility)-1.250.22Trident Texofab
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Trident Texofab vs KPR Mill Stock Performance Analysis

Loading Price Chart...

Trident Texofab
KPR Mill
Trident Texofab Stock Overview | KPR Mill Stock Overview

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Trident Texofab1.91%8.03%33.90%59.72%104.69%101.11%
KPR Mill-0.53%-3.47%5.63%-8.05%17.41%7.69%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Trident Texofab606.97%201.18%1,145.49%698.61%698.61%698.61%
KPR Mill13.31%88.23%735.50%1,293.38%4,905.17%6,394.51%

News Based Sentiment: Trident Texofab vs KPR Mill

Trident Texofab

News based Sentiment: POSITIVE

September was a month of consistently positive developments for Trident Texofab, marked by strong stock performance, positive financial results, and overwhelmingly bullish investor sentiment. The company's continued outperformance and operational efficiency suggest a strong investment case, despite high valuation metrics.

View Trident Texofab News Sentiment Analysis

KPR Mill

News based Sentiment: POSITIVE

KPR Mill Ltd. reported strong financial results for both Q4FY24 and the full fiscal year 2023-24, demonstrating consistent revenue and profit growth. The company's decision to invest ₹250 crore in expansion further strengthens the investment narrative, signaling confidence in future prospects and potential for increased earnings.

View KPR Mill News Sentiment Analysis

Performance & Financial Health Analysis: Trident Texofab vs KPR Mill

MetricTTFLKPRMILL
Market Information
Market Cap i₹5.08B₹364.48B
Market Cap CategorySmall capLarge cap
10 Day Avg. Volume i24,786236,215
90 Day Avg. Volume i20,038359,324
Last Close₹345.00₹1,065.10
52 Week Range₹146.25 - ₹345.00₹755.50 - ₹1,389.00
% from 52W High0.00%-23.32%
All-Time High₹345.00 (Oct 06, 2025)₹1,389.00 (May 05, 2025)
% from All-Time High0.00%-23.32%
Growth Metrics
Quarterly Revenue Growth0.09%0.10%
Quarterly Earnings Growth0.46%0.05%
Financial Health
Profit Margin (TTM) i0.02%0.13%
Operating Margin (TTM) i0.06%0.15%
Return on Equity (TTM) i0.05%0.16%
Debt to Equity (MRQ) i62.679.32
Cash & Liquidity
Book Value per Share (MRQ)₹46.27₹146.34
Cash per Share (MRQ)₹2.24₹16.94
Operating Cash Flow (TTM) i₹-106,030,000₹11.06B
Levered Free Cash Flow (TTM) i₹25.10M₹8.15B
Dividends
Last 12-Month Dividend Yield iN/A0.40%
Last 12-Month Dividend i₹0.00₹5.00

Valuation & Enterprise Metrics Analysis: Trident Texofab vs KPR Mill

MetricTTFLKPRMILL
Price Ratios
P/E Ratio (TTM) i158.9444.45
Forward P/E iN/A32.40
PEG Ratio i36.569.80
Price to Sales (TTM) i4.085.59
Price to Book (MRQ) i7.327.32
Market Capitalization
Market Capitalization i₹5.08B₹364.48B
Enterprise Value i₹5.04B₹364.88B
Enterprise Value Metrics
Enterprise to Revenue i4.055.58
Enterprise to EBITDA i83.3228.95
Risk & Other Metrics
Beta i-1.250.22
Book Value per Share (MRQ) i₹46.27₹146.34

Financial Statements Comparison: Trident Texofab vs KPR Mill

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)TTFLKPRMILL
Revenue/Sales i₹280.77M₹16.86B
Cost of Goods Sold i₹236.63M₹11.32B
Gross Profit i₹44.14M₹5.55B
Research & Development iN/AN/A
Operating Income (EBIT) i₹16.56M₹2.57B
EBITDA i₹25.03M₹3.46B
Pre-Tax Income i₹13.69M₹2.79B
Income Tax i₹3.53M₹664.00M
Net Income (Profit) i₹10.16M₹2.13B

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)TTFLKPRMILL
Cash & Equivalents i₹1.09M₹1.15B
Total Current Assets i₹737.44M₹33.26B
Total Current Liabilities i₹407.50M₹7.75B
Long-Term Debt i₹102.71M₹538.30M
Total Shareholders Equity i₹472.39M₹50.02B
Retained Earnings i₹77.13M₹46.56B
Property, Plant & Equipment i₹31.11M₹2.67B

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)TTFLKPRMILL
Operating Cash Flow iN/AN/A
Capital Expenditures iN/AN/A
Free Cash Flow iN/AN/A
Debt Repayment iN/AN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricTTFLKPRMILL
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Average Daily Volume (10 Day) i24,786236,215
Average Daily Volume (90 Day) i20,038359,324
Shares Outstanding i13.56M341.81M
Float Shares i7.61M110.93M
% Held by Insiders i0.38%0.68%
% Held by Institutions i0.00%0.22%

Dividend Analysis & Yield Comparison: Trident Texofab vs KPR Mill

MetricTTFLKPRMILL
Last 12-Month Dividend i₹0.00₹5.00
Last 12-Month Dividend Yield iN/A0.40%
3-Year Avg Annual Dividend i₹0.00₹4.72
3-Year Avg Dividend Yield iN/A0.26%
3-Year Total Dividends i₹0.00₹14.15
Ex-Dividend DateN/AJul 23, 2025